Terms: = Bone cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Prognosis
18 results:
1. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach.
Chaudhary RK; Patil P; Ananthesh L; Gowdru Srinivasa M; Mateti UV; Shetty V; Khanal P
Comput Biol Med; 2023 Aug; 162():107090. PubMed ID: 37295388
[TBL] [Abstract] [Full Text] [Related]
2. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract] [Full Text] [Related]
3. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.
Bezdekova R; Jelinek T; Kralova R; Stork M; Polackova P; Vsianska P; Brozova L; Jarkovsky J; Almasi M; Boichuk I; Knechtova Z; Penka M; Pour L; Sevcikova S; Hajek R; Rihova L
Br J Haematol; 2021 Oct; 195(1):95-107. PubMed ID: 34500493
[TBL] [Abstract] [Full Text] [Related]
4. Contactin 1: An Important and Emerging Oncogenic Protein Promoting cancer Progression and Metastasis.
Gu Y; Li T; Kapoor A; Major P; Tang D
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32752094
[TBL] [Abstract] [Full Text] [Related]
5. Fulminant primary cardiac lymphoma with sudden cardiac death: A case report and brief review.
Cheng JF; Lee SH; Hsu RB; Yu SC; Shun CT; Huang PS; Chen YH; Lee CM
J Formos Med Assoc; 2018 Oct; 117(10):939-943. PubMed ID: 29681417
[TBL] [Abstract] [Full Text] [Related]
6. Primary cardiac lymphoblastic B-cell lymphoma: Should we treat more intensively?
Pires Ferreira Filho LI; Ribeiro Junior HL; Pinheiro Junior ED; Pinheiro RF
J Cancer Res Ther; 2015; 11(4):1034. PubMed ID: 26881634
[TBL] [Abstract] [Full Text] [Related]
7. Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.
Potratz J; Tillmanns A; Berning P; Korsching E; Schaefer C; Lechtape B; Schleithoff C; Unland R; Schäfer KL; Müller-Tidow C; Jürgens H; Dirksen U
Mol Oncol; 2016 May; 10(5):677-92. PubMed ID: 26739507
[TBL] [Abstract] [Full Text] [Related]
8. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and flt4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract] [Full Text] [Related]
9. Plasma cell leukemia: a retrospective study of 10 cases.
Agarwal AD; Brahmbhatt BS; Parikh BP; Shah MJ
Indian J Cancer; 2014; 51(1):18-9. PubMed ID: 24947090
[TBL] [Abstract] [Full Text] [Related]
10. High levels of circulating CD34+/vegfr3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer.
Qiu H; Cao L; Wang D; Xu H; Liang Z
J Obstet Gynaecol Res; 2013 Jul; 39(7):1268-75. PubMed ID: 23803010
[TBL] [Abstract] [Full Text] [Related]
11. [Application of FICTION technique to the detection of genetic aberrations in multiple myeloma].
Wang D; Huang L; Zhang H; Geng Z; Shang Z; Zhou JF; Li CR
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):226-30. PubMed ID: 21569703
[TBL] [Abstract] [Full Text] [Related]
12. Plasma cell leukemia: concepts and management.
Liedtke M; Medeiros BC
Expert Rev Hematol; 2010 Oct; 3(5):543-9. PubMed ID: 21083471
[TBL] [Abstract] [Full Text] [Related]
13. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
[TBL] [Abstract] [Full Text] [Related]
14. Plasma cell leukemia: a rare condition.
Jiménez-Zepeda VH; Domínguez VJ
Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
[TBL] [Abstract] [Full Text] [Related]
15. The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Giles FJ; Bellamy WT; Estrov Z; O'Brien SM; Verstovsek S; Ravandi F; Beran M; Bycott P; Pithavala Y; Steinfeldt H; Reich SD; List AF; Yee KW
Leuk Res; 2006 Jul; 30(7):801-11. PubMed ID: 16332390
[TBL] [Abstract] [Full Text] [Related]
16. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis.
Timke C; Krause MF; Oppermann HC; Leuschner I; Claviez A
Pediatr Blood Cancer; 2007 Jan; 48(1):108-11. PubMed ID: 16007599
[TBL] [Abstract] [Full Text] [Related]
17. Plasma cell leukemia occurring in a patient with thrombocythemia treated with hydroxyurea and busulphan.
Candoni A; Tiribelli M; Fanin R
Leuk Lymphoma; 2004 Apr; 45(4):821-4. PubMed ID: 15160964
[TBL] [Abstract] [Full Text] [Related]
18. Primary cardiac lymphoma: report of two cases occurring in immunocompetent subjects.
Anghel G; Zoli V; Petti N; Remotti D; Feccia M; Pino P; Majolino I
Leuk Lymphoma; 2004 Apr; 45(4):781-8. PubMed ID: 15160956
[TBL] [Abstract] [Full Text] [Related]
